Speciality Medicines Ltd.
SMEPrice Range
₹117–124
Issue Size
₹ 29 Cr
Lot Size
2000 Shares
Min. Investment
₹ 2,34,000
Financial Summary
(in crores)| Particulars | FY 2022-23 |
|---|---|
| Operating Revenue | 2,317.5 |
| Other Income | 2.4 |
| Total Income | 2,319.9 |
| Total Expenses | 1,958.5 |
| Profit Before Tax | 295.57 |
| Total Profit | 169.61 |
Subscription Details
Subscription
IPO Timeline
IPO Offer Start
20 Mar 2026
IPO Offer Ends
24 Mar 2026
Listing Date
30 Mar 2026
Use of Proceeds
| # | Purpose | Amount (₹ Cr) |
|---|---|---|
| 1 | Setting up of Research and Development (R&D) Center | 126.764 |
| 2 | Product registration in the international markets and Product Development for sale | 29.925 |
| 3 | Funding for Marketing and Promotional Activities | 16.561 |
| 4 | To Meet Working Capital Requirements | 80 |
| 5 | General Corporate Purposes | 2.5 |
Promoters
Promoter Shareholding
Pre-IPO
62.16%
Promoter stake
Post-IPO
43.43%
Promoter stake
Offered to Public
23,50,000
shares
Post Share Capital
38,15,500
shares
About the Company
Our company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market. Having cultivated strong and dependable customer relationships in Specialty pharmaceuticals, we have, through our distributions, established good repo with our customers spreading across more than 20 states of India and more than 35 countries all over the worlds. Our mission is to enhance patient care by supplying high-quality, innovative medicines that address unmet medical needs. With a strong commitment to excellence, we aim to make a positive impact on the lives of patients worldwide.
Use of Proceeds
1. Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje: Manda, Tal. Umargam, Dist. Valsad, Gujarat; 2. Product Registration in International Markets and Product Development for sale in international markets. 3. Funding for Marketing and Promotional Activities. 4. To Meet Working Capital Requirements; and 5. General Corporate Purpose.